Nuveen’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204M Sell
925,982
-135,575
-13% -$37.5M 0.05% 273
2026
Q1
$314M Buy
1,061,557
+115,289
+12% +$34.2M 0.08% 188
2025
Q4
$258M Buy
946,268
+109,284
+13% +$29.7M 0.07% 220
2025
Q3
$226M Sell
836,984
-20,395
-2% -$5.55M 0.06% 246
2025
Q2
$236M Buy
857,379
+32,462
+4% +$8.83M 0.07% 237
2025
Q1
$219M Buy
824,917
+23,022
+3% +$5.68M 0.07% 239
2024
Q4
$186M Sell
801,895
-29,548
-4% -$6.79M 0.05% 271
2024
Q3
$183M Sell
831,443
-174,900
-17% -$36.2M 0.05% 284
2024
Q2
$198M Sell
1,006,343
-134,562
-12% -$27.8M 0.06% 256
2024
Q1
$246M Sell
1,140,905
-32,440
-3% -$6.81M 0.07% 227
2023
Q4
$247M Buy
1,173,345
+7,706
+0.7% +$1.64M 0.08% 208
2023
Q3
$233M Sell
1,165,639
-17,590
-1% -$3.5M 0.08% 202
2023
Q2
$219M Sell
1,183,229
-28,677
-2% -$5.3M 0.08% 210
2023
Q1
$232M Buy
1,211,906
+38,290
+3% +$6.92M 0.09% 202
2022
Q4
$197M Sell
1,173,616
-443,797
-27% -$77.1M 0.08% 239
2022
Q3
$286M Sell
1,617,413
-155,909
-9% -$30.8M 0.12% 165
2022
Q2
$363M Buy
1,773,322
+17,176
+1% +$3.64M 0.14% 139
2022
Q1
$440M Sell
1,756,146
-127,719
-7% -$30M 0.14% 138
2021
Q4
$430M Sell
1,883,865
-443,108
-19% -$97.5M 0.13% 151
2021
Q3
$450M Sell
2,326,973
-155,373
-6% -$31.5M 0.14% 143
2021
Q2
$528M Buy
2,482,346
+55,195
+2% +$11.7M 0.16% 126
2021
Q1
$496M Buy
2,427,151
+96,068
+4% +$18.9M 0.16% 124
2020
Q4
$424M Buy
2,331,083
+46,779
+2% +$7.96M 0.14% 134
2020
Q3
$382M Sell
2,284,304
-63,618
-3% -$10.7M 0.15% 141
2020
Q2
$382M Sell
2,347,922
-412,483
-15% -$73.9M 0.16% 123
2020
Q1
$477M Sell
2,760,405
-268,166
-9% -$53.4M 0.23% 100
2019
Q4
$608M Sell
3,028,571
-110,637
-4% -$22.7M 0.23% 92
2019
Q3
$663M Sell
3,139,208
-99,322
-3% -$20.8M 0.27% 74
2019
Q2
$629M Buy
3,238,530
+3,220,982
+18,355% +$594M 0.25% 84
2019
Q1
$2.89M Sell
17,548
-233
-1% -$41.2K 0.02% 589
2018
Q4
$3.35M Buy
17,781
+830
+5% +$153K 0.02% 538
2018
Q3
$2.88M Sell
16,951
-574
-3% -$96.6K 0.02% 603
2018
Q2
$2.87M Buy
17,525
+2,721
+18% +$444K 0.02% 563
2018
Q1
$2.39M Sell
14,804
-11
-0.1% -$1.75K 0.02% 593
2017
Q4
$2.16M Buy
14,815
+12,786
+630% +$1.82M 0.01% 590
2017
Q3
$275K Sell
2,029
-10,966
-84% -$1.39M ﹤0.01% 1015
2017
Q2
$1.63M Sell
12,995
-10,913
-46% -$1.31M 0.01% 649
2017
Q1
$2.84M Sell
23,908
-64,229
-73% -$7.72M 0.02% 606
2016
Q4
$10.2M Buy
88,137
+54,923
+165% +$6.11M 0.05% 450
2016
Q3
$3.47M Buy
33,214
+5,753
+21% +$601K 0.02% 616
2016
Q2
$2.67M Sell
27,461
-29,851
-52% -$2.82M 0.02% 650
2016
Q1
$5.5K Buy
57,312
+10,586
+23% +$963K 0.03% 455
2015
Q4
$4.23K Sell
46,726
-674
-1% -$63.4K 0.02% 507
2015
Q3
$4.4K Buy
47,400
+399
+0.8% +$37.9K 0.02% 519
2015
Q2
$4.37K Buy
47,001
+1,048
+2% +$97.8K 0.02% 554
2015
Q1
$4.35M Hold
45,953
0.02% 558
2014
Q4
$4.07M Buy
45,953
+24,246
+112% +$2.05M 0.02% 596
2014
Q3
$1.74M Sell
21,707
-555
-2% -$41.8K 0.01% 870
2014
Q2
$1.58M Sell
22,262
-1,058
-5% -$74.5K 0.01% 923
2014
Q1
$1.73M Sell
23,320
-488
-2% -$36.8K 0.01% 870
2013
Q4
$1.87M Sell
23,808
-165
-0.7% -$12.9K 0.01% 807
2013
Q3
$1.77M Buy
23,973
+900
+4% +$66.3K 0.01% 860
2013
Q2
$1.75M Buy
+23,073
New +$1.51M 0.01% 806

Other funds holding CME

Nuveen's CME Position: Q2 2026 in Review

Nuveen reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $37.5M and leaving 925,982 shares worth $204M. The position accounts for 0.05% of the portfolio, ranked #273.

Nuveen first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $663M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nuveen held 925,982 shares of CME Group worth $204M as of Q2 2026.
  • Nuveen sold 135,575 CME Group shares in Q2 2026, an estimated $37.5M.
  • CME Group made up 0.05% of Nuveen's portfolio in Q2 2026, its #273 holding.
  • Nuveen first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's CME Group position peaked at $663M in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.